Nivolumab plus Doxorubicin, Vinblastine and Dacarbazine for newly diagnosed advanced-stage classical Hodgkin lymphoma: CheckMate 205 Cohort D 2-year follow-up results

被引：0

作者：

Engert, A. ^{[1
]}

Domingo-Domenech, E. ^{[2
]}

Ramchandren, R. ^{[3
]}

Rueda, A. ^{[4
]}

Trneny, M. ^{[5
,6
]}

Feldman, T. ^{[7
]}

Lee, H. J. ^{[8
]}

Provencio, M. ^{[9
]}

Sillaber, C. ^{[10
]}

Cohen, J. B. ^{[11
]}

Savage, K. J. ^{[12
]}

Willenbacher, W. ^{[13
,14
]}

Sumbul, A. ^{[15
]}

Sacchi, M. ^{[15
]}

Armand, P. ^{[16
]}

Ansell, S. M. ^{[17
]}

机构：

[1] Univ Hosp Cologne, Cologne, Germany

[2] Inst Catala Oncol, Barcelona, Spain

[3] Univ Tennessee, Knoxville, TN USA

[4] Costa del Sol Hosp, Marbella, Spain

[5] Charles Univ Prague, Prague, Czech Republic

[6] Gen Univ Hosp Prague, Prague, Czech Republic

[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Hosp Univ Puerta de Hierro, Madrid, Spain

[10] Med Univ Vienna, Vienna, Austria

[11] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[12] British Columbia Canc Ctr Lymphoid Canc, Vancouver, BC, Canada

[13] Univ Innsbruck Hosp, Innsbruck, Austria

[14] OncoTyrol Ctr Personalized Canc Med, Innsbruck, Austria

[15] Bristol Myers Squibb, Princeton, NJ USA

[16] Dana Farber Canc Inst, Boston, MA 02115 USA

[17] Mayo Clin, Rochester, MN USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V611

引用

页码：162 / 162

页数：1